Current Liabilities
Current Debt
Pfizer Current Debt increased by 28.8% to $3.86B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.0%, from $3.75B to $3.86B. Over 5 years (FY 2020 to FY 2025), Current Debt shows an upward trend with a 8.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026May 5, 2026
How to read this metric
An increase suggests higher near-term cash outflows, which may pressure liquidity if not managed through refinancing or cash reserves.
Detailed definition
This represents the portion of long-term debt obligations that are due to be repaid within the next twelve months. It is...
Peer comparison
Pharmaceutical companies often manage large debt maturities related to past acquisitions, making this a key focus for credit analysts.
Metric ID:
current_portion_long_term_debtHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.69B | $2.66B | $1.64B | $260.00M | $1.28B | $2.57B | $2.56B | $3.57B | $3.57B | $2.26B | $2.25B | $1.00B | $3.75B | $3.75B | $3.75B | $3.75B | $4.25B | $4.25B | $3.00B | $3.86B |
| QoQ Change | — | -27.8% | -38.6% | -84.1% | +390.8% | +101.1% | -0.2% | +39.3% | -0.1% | -36.6% | -0.3% | -55.6% | +274.1% | +0.0% | +0.0% | +0.1% | +13.3% | +0.0% | -29.4% | +28.8% |
| YoY Change | — | — | — | — | -65.4% | -3.6% | +56.5% | >999% | +179.4% | -11.9% | -12.0% | -71.9% | +5.0% | +65.8% | +66.2% | +274.5% | +13.4% | +13.4% | -20.0% | +3.0% |
Range$260.00M – $4.25B
CAGR+1.0%
Avg YoY Growth+110.3%
Median YoY Growth+9.2%
Current Debt at Other Companies
Frequently Asked Questions
- What is Pfizer's current debt?
- Pfizer (PFE) reported current debt of $3.86B in Q1 2026.
- How has Pfizer's current debt changed year-over-year?
- Pfizer's current debt increased by 3.0% year-over-year, from $3.75B to $3.86B.
- What is the long-term trend for Pfizer's current debt?
- Over 5 years (2020 to 2025), Pfizer's current debt has grown at a 8.4% compound annual growth rate (CAGR), from $2.00B to $3.00B.
- What does current debt mean?
- The amount of long-term debt that must be paid back within the next year.